Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Nash

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Drugs - Real World Outcomes|September 13, 2022
Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2- Metastatic Breast Cancer Treated with AbemaciclibEmily Nash Smyth, Julie Beyrer, Kimberly R Saverno, et al.
NPJ Science of Food|May 6, 2026
Systemic drivers of toxic food adulteration: lead chromate in turmeric across eastern IndiaJenna E Forsyth, Manu Sinha, Amogh Bandekar, et al.
Journal of Analytical Toxicology|August 16, 2020
Fentanyl and Driving ImpairmentTimothy P Rohrig, Emily Nash, Kei A Osawa, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|April 4, 2023
Mitigating Racism and Implicit Bias in Psychiatric Notes: a Quality Improvement Project Addressing How Race and Ethnicity Are DocumentedEmily Nash, Jacob E Perlson, Ruth McCann, et al.
Scientific Reports|April 27, 2024
Rapid Market Screening to assess lead concentrations in consumer products across 25 low- and middle-income countriesAelita Sargsyan, Emily Nash, Gordon Binkhorst, et al.
Drug and Alcohol Review|June 22, 2022
Management of alcohol and other drug issues in Special Health Accommodation during the COVID-19 Delta variant outbreak in Sydney, 2021Emily Nash, Emily Walker, Joshua Watt, et al.
The Medical Journal of Australia|July 17, 2021
Drug-induced liver injury in Australia, 2009-2020: the increasing proportion of non-paracetamol cases linked with herbal and dietary supplementsEmily Nash, Abdul-Hamid Sabih, John Chetwood, et al.
The Oncologist|June 26, 2023
Clinicogenomic factors and treatment patterns among patients with advanced non-small cell lung cancer with or without brain metastases in the United StatesEmily Nash Smyth, Jincy John, Ramon V Tiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2023
Clinical and Genomic Characteristics of Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 InhibitorsXi Rao, Yongmei Chen, Julie Beyrer, et al.
Advances in Therapy|March 30, 2023
Characteristics and Outcomes in Cases of US Male Patients with Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical PracticeAlistair Ring, Meghan Karuturi, Emily Nash Smyth, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Drugs - Real World Outcomes|September 13, 2022
Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2- Metastatic Breast Cancer Treated with AbemaciclibEmily Nash Smyth, Julie Beyrer, Kimberly R Saverno, et al.
NPJ Science of Food|May 6, 2026
Systemic drivers of toxic food adulteration: lead chromate in turmeric across eastern IndiaJenna E Forsyth, Manu Sinha, Amogh Bandekar, et al.
Journal of Analytical Toxicology|August 16, 2020
Fentanyl and Driving ImpairmentTimothy P Rohrig, Emily Nash, Kei A Osawa, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|April 4, 2023
Mitigating Racism and Implicit Bias in Psychiatric Notes: a Quality Improvement Project Addressing How Race and Ethnicity Are DocumentedEmily Nash, Jacob E Perlson, Ruth McCann, et al.
Scientific Reports|April 27, 2024
Rapid Market Screening to assess lead concentrations in consumer products across 25 low- and middle-income countriesAelita Sargsyan, Emily Nash, Gordon Binkhorst, et al.
Drug and Alcohol Review|June 22, 2022
Management of alcohol and other drug issues in Special Health Accommodation during the COVID-19 Delta variant outbreak in Sydney, 2021Emily Nash, Emily Walker, Joshua Watt, et al.
The Medical Journal of Australia|July 17, 2021
Drug-induced liver injury in Australia, 2009-2020: the increasing proportion of non-paracetamol cases linked with herbal and dietary supplementsEmily Nash, Abdul-Hamid Sabih, John Chetwood, et al.
The Oncologist|June 26, 2023
Clinicogenomic factors and treatment patterns among patients with advanced non-small cell lung cancer with or without brain metastases in the United StatesEmily Nash Smyth, Jincy John, Ramon V Tiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2023
Clinical and Genomic Characteristics of Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 InhibitorsXi Rao, Yongmei Chen, Julie Beyrer, et al.
Advances in Therapy|March 30, 2023
Characteristics and Outcomes in Cases of US Male Patients with Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical PracticeAlistair Ring, Meghan Karuturi, Emily Nash Smyth, et al.
Pageof 6